Oils4cure S.L.

Neurology and Epilepsy

Oils4cure S.L. is involved in clinical research focused on refractory epilepsy linked to tuberous sclerosis complex, with attention to seizure burden in patients whose epilepsy is difficult to control.

  • Seizure reduction in drug-resistant epilepsy
  • Tuberous sclerosis complex-associated neurological disease
  • Epileptic seizure management

The sponsor’s research activity is centered on treatment options for epilepsy syndromes with significant neurological impact, particularly where standard control remains limited.

Rare Disease Research

The clinical portfolio includes a rare-disease setting involving tuberous sclerosis complex, reflecting interest in conditions with complex neurological and systemic manifestations.

  • Rare neurological disorders
  • TSC-related epilepsy
  • Uncontrolled seizure disorders

This area places emphasis on patient groups with limited therapeutic options and persistent epilepsy symptoms.

Safety and Tolerability in Neurological Treatment

Research activity also addresses the safety profile of treatment in patients with refractory seizures, with clinical interest in how therapy is tolerated in a vulnerable neurological population.

  • Treatment safety
  • Therapy tolerability
  • Neurological patient monitoring

These interests align with the management of chronic epileptic disorders requiring ongoing clinical oversight.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Full Spectrum Cannabis Extract (Dronabinol, Cannabidiol) for Patients with Hard-to-Treat Epilepsy in Tuberous Sclerosis Complex

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Spain